Literature DB >> 35765691

Harmonizing Magnetic Resonance Imaging Protocols for Veterans With Multiple Sclerosis.

Francesca Bagnato1,2,3, Mitchell Wallin1,4,5.   

Abstract

Background: Magnetic resonance imaging (MRI) assists with the diagnosis of multiple sclerosis (MS), allows for timely therapeutic intervention, and for the evaluation of disease progression, treatment effect, and safety. An international task force including representatives from the Veterans Health Administration worked together to update guidelines for imaging the brain, spinal cord, and optic nerve in people with MS. Observations: This commentary communicates the core message of the 2021 MAGNIMS-CMSC-NAIMS Consensus Recommendations on the Use of MRI in Patients With Multiple Sclerosis as part of the MS Center of Excellence effort to align with contemporary guidelines, apply the highest scientific standards, and achieve consistent outcomes for veterans with MS. To implement and disseminate these proposed recommendations within the Veterans Health Administration, a workgroup was formed at the end of 2020, which discussed a modified version of the 2021 MRI Guidelines to accommodate US Department of Veterans Affairs medical centers that had fewer imaging resources as well as veterans' needs. Conclusions: Standardized MRI protocols are fundamental for the care of veterans with MS. Mitigating interscan variabilities is recognized as a priority by scientific and clinical expert committees.
Copyright © 2022 Frontline Medical Communications Inc., Parsippany, NJ, USA.

Entities:  

Year:  2022        PMID: 35765691      PMCID: PMC9227743          DOI: 10.12788/fp.0251

Source DB:  PubMed          Journal:  Fed Pract        ISSN: 1078-4497


  14 in total

Review 1.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients.

Authors:  Mike P Wattjes; Àlex Rovira; David Miller; Tarek A Yousry; Maria P Sormani; Maria P de Stefano; Mar Tintoré; Cristina Auger; Carmen Tur; Massimo Filippi; Maria A Rocca; Franz Fazekas; Ludwig Kappos; Chris Polman
Journal:  Nat Rev Neurol       Date:  2015-09-15       Impact factor: 42.937

Review 2.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Authors:  Alan J Thompson; Brenda L Banwell; Frederik Barkhof; William M Carroll; Timothy Coetzee; Giancarlo Comi; Jorge Correale; Franz Fazekas; Massimo Filippi; Mark S Freedman; Kazuo Fujihara; Steven L Galetta; Hans Peter Hartung; Ludwig Kappos; Fred D Lublin; Ruth Ann Marrie; Aaron E Miller; David H Miller; Xavier Montalban; Ellen M Mowry; Per Soelberg Sorensen; Mar Tintoré; Anthony L Traboulsee; Maria Trojano; Bernard M J Uitdehaag; Sandra Vukusic; Emmanuelle Waubant; Brian G Weinshenker; Stephen C Reingold; Jeffrey A Cohen
Journal:  Lancet Neurol       Date:  2017-12-21       Impact factor: 44.182

3.  The Multiple Sclerosis Centers of Excellence: A Model of Excellence in the VA.

Authors:  Michelle H Cameron; Jodie K Haselkorn; Mitchell T Wallin
Journal:  Fed Pract       Date:  2020-04

Review 4.  Is administration of gadolinium-based contrast media to pregnant women and small children justified?

Authors:  Pia C Sundgren; Peter Leander
Journal:  J Magn Reson Imaging       Date:  2011-10       Impact factor: 4.813

5.  Multiple sclerosis: gadolinium enhancement in MR imaging.

Authors:  R I Grossman; F Gonzalez-Scarano; S W Atlas; S Galetta; D H Silberberg
Journal:  Radiology       Date:  1986-12       Impact factor: 11.105

6.  An International Standardized Magnetic Resonance Imaging Protocol for Diagnosis and Follow-up of Patients with Multiple Sclerosis: Advocacy, Dissemination, and Implementation Strategies.

Authors:  Lori Saslow; David K B Li; June Halper; Brenda Banwell; Frederik Barkhof; Laura Barlow; Kathleen Costello; Peter Damiri; Jeffrey Dunn; Shivraman Giri; Micki Maes; Sarah A Morrow; Scott D Newsome; Jiwon Oh; Friedemann Paul; Patrick Quarterman; Daniel S Reich; Jason R Shewchuk; Russell Takeshi Shinohara; Wim Van Hecke; Kim van de Ven; Mitchell T Wallin; Jerry S Wolinsky; Anthony Traboulsee
Journal:  Int J MS Care       Date:  2020-10-27

7.  Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis.

Authors:  A Traboulsee; J H Simon; L Stone; E Fisher; D E Jones; A Malhotra; S D Newsome; J Oh; D S Reich; N Richert; K Rammohan; O Khan; E-W Radue; C Ford; J Halper; D Li
Journal:  AJNR Am J Neuroradiol       Date:  2015-11-12       Impact factor: 3.825

8.  The prevalence of MS in the United States: A population-based estimate using health claims data.

Authors:  Mitchell T Wallin; William J Culpepper; Jonathan D Campbell; Lorene M Nelson; Annette Langer-Gould; Ruth Ann Marrie; Gary R Cutter; Wendy E Kaye; Laurie Wagner; Helen Tremlett; Stephen L Buka; Piyameth Dilokthornsakul; Barbara Topol; Lie H Chen; Nicholas G LaRocca
Journal:  Neurology       Date:  2019-02-15       Impact factor: 9.910

Review 9.  A new way to estimate neurologic disease prevalence in the United States: Illustrated with MS.

Authors:  Lorene M Nelson; Mitchell T Wallin; Ruth Ann Marrie; W J Culpepper; Annette Langer-Gould; Jon Campbell; Stephen Buka; Helen Tremlett; Gary Cutter; Wendy Kaye; Laurie Wagner; Nicholas G Larocca
Journal:  Neurology       Date:  2019-02-15       Impact factor: 9.910

Review 10.  2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis.

Authors:  Mike P Wattjes; Olga Ciccarelli; Daniel S Reich; Brenda Banwell; Nicola de Stefano; Christian Enzinger; Franz Fazekas; Massimo Filippi; Jette Frederiksen; Claudio Gasperini; Yael Hacohen; Ludwig Kappos; David K B Li; Kshitij Mankad; Xavier Montalban; Scott D Newsome; Jiwon Oh; Jacqueline Palace; Maria A Rocca; Jaume Sastre-Garriga; Mar Tintoré; Anthony Traboulsee; Hugo Vrenken; Tarek Yousry; Frederik Barkhof; Àlex Rovira
Journal:  Lancet Neurol       Date:  2021-06-14       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.